“Pan-coronavirus” vaccines: RNA Polymerase Emerges as a Vaccine Target

Resistance to COVID-19 infection has been observed in health care workers and has been attributed to the presence of memory T cells that target the RNA polymerase in the RTC (replication transcription complex), thereby preventing infection. This makes RNA polymerase an important target for making a pan-coronavirus vaccine that will be effective against SARS-CoV-2 and its other variants of concern (VoC’s), but also against the family of Coronaviruses in general. 

COVID-19 pandemic is now almost 2 years old and has caused havoc among the world by disrupting world economy and halting the normal way of living. Millions have died and many more have been infected with the disease leading to high levels of morbidity. However, there have been instances where people have cleared the infection from the system so quickly that they didn’t test positive for the virus or developed antibodies against it. This resistance has been attributed to the memory T cells-possibly those that are produced after exposure of the human system to such viruses

In a recent study published in Nature by Swalding et al., blood samples from 60 health care workers, who were at high risk of developing COVID-19 due to their exposure, were examined and found out to be negative for the virus and for the antibodies against the virus1. It is hypothesised that pre-existing memory T-cells, with cross-protective potential against SARS-CoV-2, expand in vivo to provide rapid viral clearance, thus aborting infection. These T cells are directed against the RNA polymerase in the RTC (replication transcription complex), rather than any other structural protein of the virus. These memory T cells could have been generated in the health care workers by being exposed to other respiratory or related corona viruses, albeit there is no direct evidence of the same. It is also possible that there were other environmental triggers that led to the generation of these T cells. In addition, these sero-negative individuals also showed an increase in IFI27, a protein indicative of abortive SARS-CoV-2 infection. IFI27 is an interferon alpha inducible protein that is overexpressed upon exposure to a variety of respiratory viruses, including SARS-CoV-2. This may also be responsible for viral clearance in individuals, pre-exposed to other respiratory viruses, and then infected with SARS-CoV-2. 

The fact that the memory T cells are directed against the RNA polymerase (being the most conserved among the human coronaviruses that cause common cold and SARS-CoV-2), makes this enzyme an important target to develop a pan-coronavirus vaccine that would not only be directed against SARS-CoV-2 and its other variants of concern (VoC’s) that have evolved as a result of mutations in the spike protein leading to more severe disease, but also against the family of Coronaviruses in general. 

*** 

Source:  

Swadling, L., Diniz, M.O., Schmidt, N.M. et al. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature (2021). https://doi.org/10.1038/s41586-021-04186-8 

***

Latest

Meteor Produces Daytime Bolide and Sonic Boom Across New England  

A loud sonic boom was heard and a fireball seen around 18:06 UTC Saturday 30...

Carbon-free Ferrocene Analog Synthesised

The synthesis of the first carbon-free inorganic sandwich compound  (an osmium...

Outbreak of Bundibugyo Ebolavirus in DR Congo and Uganda

The current orthoebolavirus outbreak in Democratic Republic of Congo...

Neanderthals Performed Dental Caries Interventions 59,000 Years Ago

Prehistoric dentistry is far older than 14,000 years as...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Newsletter

Don't miss

SARS-CoV-2: How Serious is B.1.1.529 variant, now named Omicron

The B.1.1.529 variant was first reported to WHO from...

Artificial Intelligence (AI) Systems Conduct Research in Chemistry Autonomously  

Scientists have successfully integrated latest AI tools (e.g. GPT-4)...

Ischgl Study: Development of Herd Immunity and Vaccine Strategy against COVID-19

Routine sero-surveillance of the population to estimate presence of...

The Gene variant that protects against severe COVID-19

A gene variant of OAS1 has been implicated in...

ISARIC Study Indicates How Social Distancing Could Be Fine-tuned

The recently completed UK-wide, ISARIC Study on analysis of...

WAIfinder: a new digital tool to maximise connectivity across the UK AI landscape 

UKRI has launched WAIfinder, an online tool to showcase...
Rajeev Soni
Rajeev Sonihttps://web.archive.org/web/20220523060124/https://www.rajeevsoni.org/publications/
Dr. Rajeev Soni (ORCID ID : 0000-0001-7126-5864) has a Ph.D. in Biotechnology from the University of Cambridge, UK and has 25 years of experience working across the globe in various institutes and multinationals such as The Scripps Research Institute, Novartis, Novozymes, Ranbaxy, Biocon, Biomerieux and as a principal investigator with US Naval Research Lab in drug discovery, molecular diagnostics, protein expression, biologic manufacturing and business development.

Meteor Produces Daytime Bolide and Sonic Boom Across New England  

A loud sonic boom was heard and a fireball seen around 18:06 UTC Saturday 30 May 2026 across New England in the northeastern region of the United States. The bright fireball (bolide) was...

Carbon-free Ferrocene Analog Synthesised

The synthesis of the first carbon-free inorganic sandwich compound  (an osmium ion sandwiched between two boron rings), is a fundamental advancement in chemistry. This was sought by chemists for...

Outbreak of Bundibugyo Ebolavirus in DR Congo and Uganda

The current orthoebolavirus outbreak in Democratic Republic of Congo (DRC) and Uganda is confirmed to be caused by the species Orthoebolavirus bundibugyoense (Bundibugyo virus),...